Your browser doesn't support javascript.
loading
Protein Interaction Mapping Identifies RBBP6 as a Negative Regulator of Ebola Virus Replication.
Batra, Jyoti; Hultquist, Judd F; Liu, Dandan; Shtanko, Olena; Von Dollen, John; Satkamp, Laura; Jang, Gwendolyn M; Luthra, Priya; Schwarz, Toni M; Small, Gabriel I; Arnett, Eusondia; Anantpadma, Manu; Reyes, Ann; Leung, Daisy W; Kaake, Robyn; Haas, Paige; Schmidt, Carson B; Schlesinger, Larry S; LaCount, Douglas J; Davey, Robert A; Amarasinghe, Gaya K; Basler, Christopher F; Krogan, Nevan J.
Afiliação
  • Batra J; Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Hultquist JF; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA; Division o
  • Liu D; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63105, USA.
  • Shtanko O; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
  • Von Dollen J; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Satkamp L; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Jang GM; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Luthra P; Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA.
  • Schwarz TM; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Small GI; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63105, USA.
  • Arnett E; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
  • Anantpadma M; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
  • Reyes A; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
  • Leung DW; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63105, USA.
  • Kaake R; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Haas P; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Schmidt CB; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA.
  • Schlesinger LS; Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
  • LaCount DJ; Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, USA.
  • Davey RA; Department of Virology and Immunology, Texas Biomedical Research Institute, San Antonio, TX 78245, USA.
  • Amarasinghe GK; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63105, USA.
  • Basler CF; Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA 30303, USA. Electronic address: cbasler@gsu.edu.
  • Krogan NJ; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA; Quantitative Biosciences Institute, University of California, San Francisco, San Francisco, CA 94158, USA; J. David Gladstone Institutes, San Francisco, CA 94158, USA. Electronic
Cell ; 175(7): 1917-1930.e13, 2018 12 13.
Article em En | MEDLINE | ID: mdl-30550789
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Virais / Replicação Viral / Proteínas de Transporte / Doença pelo Vírus Ebola / Proteínas de Ligação a DNA / Ebolavirus Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fatores de Transcrição / Proteínas Virais / Replicação Viral / Proteínas de Transporte / Doença pelo Vírus Ebola / Proteínas de Ligação a DNA / Ebolavirus Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article